Loading clinical trials...
Loading clinical trials...
AACR Adaptive Biomarker-Driven Organ Preservation Trial In Gastroesophageal Adenocarcinomas (AACR-ADOPT-GEA)
Conditions
Interventions
Tislelizumab
Leucovorin
+3 more
Start Date
May 1, 2026
Primary Completion Date
June 1, 2028
Completion Date
December 1, 2028
Last Updated
April 7, 2026
NCT05733689
NCT07282912
NCT07176312
NCT06529822
NCT06245356
NCT07544589
Lead Sponsor
American Association for Cancer Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions